Last reviewed · How we verify

ketamine in local intravenous anesthesia

Assiut University · Phase 1 active Small molecule Quality 0/100

ketamine in local intravenous anesthesia is a Small molecule drug developed by Assiut University. It is currently in Phase 1 development.

At a glance

Generic nameketamine in local intravenous anesthesia
SponsorAssiut University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ketamine in local intravenous anesthesia

What is ketamine in local intravenous anesthesia?

ketamine in local intravenous anesthesia is a Small molecule drug developed by Assiut University.

Who makes ketamine in local intravenous anesthesia?

ketamine in local intravenous anesthesia is developed by Assiut University (see full Assiut University pipeline at /company/assiut-university).

What development phase is ketamine in local intravenous anesthesia in?

ketamine in local intravenous anesthesia is in Phase 1.

Related